2-Chloro-N-{4H,5H,6H-cyclopenta[d][1,3]thiazol-2-yl}acetamide

Catalog No.: 
ACLNWE332
CAS No.: 
1249003-51-7
Molecular Formula: 
C8H9ClN2OS
Molecular Weight: 
216.69
2-Chloro-N-{4H,5H,6H-cyclopenta[d][1,3]thiazol-2-yl}acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$117.00InquiryInquiry
100mg95%$164.00InquiryInquiry
250mg95%$227.00InquiryInquiry
1g95%$552.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-N-{4H,5H,6H-cyclopenta[d][1,3]thiazol-2-yl}acetamide
IUPAC Name2-chloro-N-(5,6-dihydro-4H-cyclopenta[d]thiazol-2-yl)acetamide
MDL No.MFCD14649122
Molecular FormulaC8H9ClN2OS
Molecular Weight216.69
SMILESO=C(NC1=NC2=C(CCC2)S1)CCl
InChI KeyJRHGKKOMFOJBAD-UHFFFAOYSA-N
Synonym2-chloro-N-{4H,5H,6H-cyclopenta[d][1,3]thiazol-2-yl}acetamide;Acetamide, 2-chloro-N-(5,6-dihydro-4H-cyclopentathiazol-2-yl)-
CAS No.1249003-51-7

Synthetic Route by SureRoute

1. ACLNWE332 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNJSC528 route compound structure diagram
    ACNJSC52853051-97-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLNWE332 route product structure diagram
    ACLNWE3321249003-51-7
Inquiry

2. ACLNWE332 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNJSC528 route compound structure diagram
    ACNJSC52853051-97-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLNWE332 route product structure diagram
    ACLNWE3321249003-51-7
Inquiry

3. ACLNWE332 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNJSC528 route compound structure diagram
    ACNJSC52853051-97-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLNWE332 route product structure diagram
    ACLNWE3321249003-51-7
Inquiry

Comments (0)